{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "15063462", "DateCompleted": {"Year": "2004", "Month": "11", "Day": "23"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0731-7085", "JournalIssue": {"Volume": "35", "Issue": "2", "PubDate": {"Year": "2004", "Month": "Apr", "Day": "16"}}, "Title": "Journal of pharmaceutical and biomedical analysis", "ISOAbbreviation": "J Pharm Biomed Anal"}, "ArticleTitle": "Chemiluminescence and LC-MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers.", "Pagination": {"StartPage": "277", "EndPage": "287", "MedlinePgn": "277-87"}, "Abstract": {"AbstractText": ["The metabolic fate of nitric oxide (NO) released from nitroaspirin, benzoic acid, 2-(acetyloxy)-3-[(nitrooxy)methyl]phenyl ester (NCX 4016), the lead compound of a new class of NO-releasing non-steroidal anti-inflammatory drugs (NO-NSAIDs) has been studied in eight healthy male Caucasian subjects following p.o. administration of 1600 mg (single dose), by monitoring at different times in plasma the bioactive storage forms of NO, S-nitrosothiols (RSNO) and its oxidation products (NOx). Plasma levels of NOx and RSNO and urinary levels of NOx were determined by an ozone-based chemiluminescent assay using a sensitive Nitric Oxide Analyzer (LOQ: 10 pmol NO injected). In parallel plasma samples were analyzed by a newly developed LC-MS/MS method for analysis of NCX 4015, the metabolite bearing the nitrate ester function. Using MS/MS with multiple reaction monitoring (MRM) in negative ion mode for NCX 4015 and the internal standard (NCX 4015- 13C-D2) it was possible to detect with sufficient accuracy and precision the metabolite in plasma with a quantification limit of 78.1 ng ml(-1). Concentration versus time profile of plasma NCX 4015 gave a Cmax value of 161.94 +/- 47.4 ng ml(-1) and a tmax 4.5 +/- 1 h. The results indicate that both NOx and RSNO (these last for the first time determined in vivo in man following oral administration of a NO-donor drug) are effective plasma markers of NO release in vivo, the latter being an earlier indicator of NO distribution (tmax 2.0 +/- 0.6 h versus 5.4 +/- 1.2 h)."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Istituto Chimico Farmaceutico Tossicologico, University of Milan, Viale Abruzzi 42, 20131 Milan, Italy. marina.carini@unimi.it"}], "Identifier": [], "LastName": "Carini", "ForeName": "Marina", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Aldini", "ForeName": "Giancarlo", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Orioli", "ForeName": "Marica", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Piccoli", "ForeName": "Angela", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tocchetti", "ForeName": "Paola", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Facino", "ForeName": "Roberto Maffei", "Initials": "RM"}], "PublicationTypeList": ["Clinical Trial", "Clinical Trial, Phase I", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Pharm Biomed Anal", "NlmUniqueID": "8309336", "ISSNLinking": "0731-7085"}, "ChemicalList": [{"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "EH04H13L6B", "NameOfSubstance": "nitroaspirin"}, {"RegistryNumber": "R16CO5Y76E", "NameOfSubstance": "Aspirin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "analysis", "chemistry"], "DescriptorName": "Aspirin"}, {"QualifierName": [], "DescriptorName": "Chromatography, Liquid"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Luminescent Measurements"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": ["analysis", "metabolism"], "DescriptorName": "Nitric Oxide"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "8", "Day": "5"}, {"Year": "2003", "Month": "8", "Day": "5"}, {"Year": "2003", "Month": "9", "Day": "23"}, {"Year": "2004", "Month": "4", "Day": "6", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "12", "Day": "16", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "4", "Day": "6", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15063462", "10.1016/S0731-7085(03)00531-4", "S0731708503005314"]}}], "PubmedBookArticle": []}